Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-19

Clinical Trial Update: Cannabidiol in the Treatment of Opioid Use Disorder [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 trial evaluating cannabidiol as a treatment for opioid use disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cannabidiol (cannabidiol)

Snippet

Sponsor: Yasmin Hurd | Conditions: Opioid Use Disorder | Phase 2 | Status: COMPLETED